Michaela Fojtů

Senior Scientist, Preclinical Pharmacology SOTIO Biotech a.s.

Seminars

Monday 3rd November 2025
Presentation Sneak Peek:

Showcasing Novel Pharmacology & Translational Aspects of SOT106 Targeting LRRC15 in Solid Tumors

  • Describing pharmacological characterization of SOT106, including LRRC15 expression within different cell populations in the TME with emphasis on pivotal role in tumor biology
  • Developing SOT106 diagnostic antibody tailored to optimize patient selection to identify those who could benefit from therapy
  • Exploring the potential of SOT106 combination therapies and how these approaches can elevate its full therapeutic potential

Michaela Fojtů - 16th World ADC San Diego